SYMBIOMIX THERAPEUTICS, LLC

Profile

Company Names

SYMBIOMIX THERAPEUTICS, LLC

Addresses

105 LOCK STREET SUITE 409, NEWARK, NJ 07103

Phone Numbers

609-722-7250

 

Entity Type:

LIMITED LIABILITY COMPANY

Industry:

PHARMACEUTICALS

Year Incorporated:

2012

State Incorporated:

DELAWARE

Total Amount Raised:

$25,545,389.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2016-04-22 
$6,000,000.00 
$6,000,000.00 
$0.00 
Equity 
1
2013-05-03 
$19,545,389.00 
$32,545,389.00 
$13,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOSEPH 
 
AMPREY 
EXECUTIVE OFFICER
ZYNGENIA, INC.   |  SYMBIOMIX THERAPEUTICS, LLC
BEN 
 
AUSPITZ 
DIRECTOR
LIGOCYTE PHARMACEUTICALS INC   |  ULTRAGENYX PHARMACEUTICAL INC.   |  SYMBIOMIX THERAPEUTICS, LLC   |  UNUM THERAPEUTICS, INC.   |  PRECISION BIOSCIENCES INC   |  COMPASS THERAPEUTICS LLC   |  CHECKMATE PHARMACEUTICALS, INC.   |  INDALO THERAPEUTICS, INC.   |  MEVES PHARMACEUTICALS, INC.   |  ZERO POINT FIVE THERAPEUTICS, INC.   |  ANTLIA BIOSCIENCE, INC.
THOMAS 
 
BECK 
DIRECTOR
VICEPT THERAPEUTICS, INC.   |  MERSANA THERAPEUTICS INC   |  DIMENSION THERAPEUTICS, INC.   |  SYMBIOMIX THERAPEUTICS, LLC   |  MERSANA THERAPEUTICS, INC.   |  R2I HOLDINGS, LLC   |  AKRIVEIA THERAPEUTICS, LLC   |  PROMENTIS PHARMACEUTICALS, INC.
KAREN 
 
DAWES 
DIRECTOR
INSPIRATION BIOPHARMACEUTICALS INC   |  SYMBIOMIX THERAPEUTICS, LLC   |  MEDICENNA THERAPEUTICS CORP.   |  PAXMEDICA, INC.
RISHI 
 
GUPTA 
DIRECTOR
GELESIS INC   |  SIENTRA, INC.   |  AVITIDE, INC.   |  SYMBIOMIX THERAPEUTICS, LLC   |  DIMENSION THERAPEUTICS, INC.   |  MEVES PHARMACEUTICALS, INC.   |  ATTENUA, INC.   |  TURNSTONE BIOLOGICS CORP.   |  GOLDEN TEAK CAPITAL L.P.   |  NEUROPACE INC   |  VERONA PHARMA PLC   |  CHARM THERAPEUTICS INC.   |  DELFI DIAGNOSTICS, INC.   |  AER THERAPEUTICS, INC.   |  HELICORE BIOVENTURES I, INC.   |  ENLIVEN THERAPEUTICS, INC.   |  WILSHIRE SELECTIVE OPPORTUNITIES PROGRAM SPC - WILSOP SEGREGATED PORTFOLIO 5
ROBERT 
 
JACKS 
EXECUTIVE OFFICER, DIRECTOR
SYMBIOMIX THERAPEUTICS, LLC   |  SPARROW PHARMACEUTICALS, INC.
KLAUS 
 
VEITINGER 
DIRECTOR
PROMENTIS PHARMACEUTICALS, INC.   |  BIOLEX THERAPEUTICS, INC.   |  RELYPSA INC   |  INTERCEPT PHARMACEUTICALS INC   |  SYMBIOMIX THERAPEUTICS, LLC   |  TRICIDA, INC.   |  CRANIOVATION, INC.   |  SPARROW PHARMACEUTICALS, INC.   |  NEUROGASTRX, INC.   |  ALPHEUS MEDICAL, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2016-05-03
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-04-22 
2014-07-09
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-05-03 
2014-07-09
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-05-03 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#